The letter provides further detail:
The two articles had some figures with the same panels used for both papers despite being experiments from two different cancers. The figures also have some panels repeated from and identical to an earlier paper studying a third type of cancer.
The Investigation Committee reviewed in detail the analytic methods and findings of the Inquiry Committee. It unanimously agreed that there were numerous similarities between the figures in question, including the location and shape of streak and spot artifacts, as well as band morphologies were noted. This was concluded by the Committee to support the allegation of data falsification or fabrication and research misconduct.
It was determined by the Inquiry Committee that several of the figures in question, alleged to be manipulated images from the same source rearranged and relabeled in the two publications, were first published in a third publication (3). . .
It was also noted that although the 2002 article, for which Dr. Tanaka was the first author, did not include a representation of "Codon 453," which was apparently not present in the targeted population, the subsequent papers, which utilized the same population, included panels labeled "codon 453."
Overall, the committee concluded that there was clear evidence of intentional manipulation and misrepresentation of the data, even though the figures were meant only to be illustrative of genotyping results. The above figures contained evidence of intentional data fabrication or falsification, and that this constituted instances of research misconduct. . . Based on these conclusions, we and the Committee recommend that both Clinical Cancer Research and Cancer Research assess these articles for correction or retraction. To request permission to re-use all or part of this article, use this link
